Deep Tech Startups
7,090 companies tagged Deep Tech, with their investors and founders.
Fount Bio is a life science company developing a pipeline of products for medical and beauty applications, combining bioorthogonal chemistry with glycopolymer science. It targets the aesthetics, consumer beauty, and medicine markets.
0 investors
Friedman and Bruya (F&B) is a women-owned environmental testing laboratory offering regulatory and specialty analytical testing of soil, sludge, and non-potable water for private and public sector clients. Based in Seattle, it serves Superfund and other environmental compliance needs under NELAP accreditation.
0 investors
FYR Medical develops light field extended reality surgical loupes, combining optics, digital imaging, and real-time computer graphics to augment visualization for surgeons in the operating room. The company builds hardware and software for advanced visualization aimed at the medical and surgical industry.
0 investors
Garwood Medical Devices develops technologies to treat bacterial biofilm infections associated with implants, advancing standards of care for patients.
0 investors
General Graphene manufactures chemical vapor deposition (CVD) graphene and carbon-based materials at industrial scale using proprietary roll-to-roll technology. The company supplies graphene to research labs and industrial partners for application development across diverse industries.
0 investors
Generian Pharmaceuticals is a preclinical biotechnology company developing orally available small molecule therapeutics for diseases with high unmet need, particularly conditions currently treated by biologics. It targets age-related diseases including metabolic disorders, neurodegeneration, and inflammation.
0 investors
Genesis Innovation Group provides comprehensive medical device development services from ideation through commercialization, serving early-stage entrepreneurs and innovators with strategic guidance, technical expertise, and industry relationships.
0 investors
GenrAb develops neuroprotective therapies derived from the human immune system to treat neurological diseases including ALS, Parkinson's, Alzheimer's, and Multiple Sclerosis. The company addresses unmet needs in neurodegeneration treatment by harnessing immunological pathways to prevent disease progression.
0 investors
GigaGen, a subsidiary of Grifols, develops recombinant polyclonal and monoclonal antibody therapies for immunodeficiencies, infectious diseases, transplant rejection, and cancer using single-cell discovery technologies. The company runs a pipeline of drug candidates including a lead CTLA-4 oncology asset and recombinant hyperimmunes for hepatitis B, rabies, and botulinum toxin.
0 investors
Global Innovations, Inc. (GII) designs and integrates smart seismic sensor systems (ISSS), including early warning border and zone security systems for defense and security applications. The technology is also marketed for oil and gas exploration, medical diagnostic equipment, and other industrial uses, with the underlying sensor components developed by sister company Precision Sensors and Instruments, LLC.
0 investors
Goldenrod Therapeutics develops brain-penetrant phosphodiesterase 4 inhibitors for neurological and neuropsychiatric disorders, focusing on overcoming tolerability limitations of earlier PDE4 inhibitors to address neuroinflammation.
0 investors
Global Science & Technology, Inc. (GST) provides scientific and technical services supporting government programs such as NOAA and NASA, including satellite data processing, remote sensing image processing, and cloud computing applications. Its work covers areas like sea surface temperature algorithm development, ocean color, and satellite oceanography for federal science agencies.
0 investors
Graham Corporation is a publicly traded manufacturer of mission-critical engineered products serving defense, space, energy, and advanced materials sectors. The company operates through independently managed business units while providing centralized support in capital allocation, M&A, and leadership development.
0 investors
Gravity Jack is a digital agency that builds custom mobile apps, augmented reality, virtual reality, computer vision, and Web3 experiences for Fortune 500 companies, agencies, and US Department of Defense clients. Founded in 2009, it holds patents in the AR and computer vision space and is a preferred developer for the Vuforia and 8th Wall platforms.
0 investors
Green Source Holdings is an Austin-based holding company that identifies, builds, and scales technology companies focused on resource efficiency and disruptive innovation. Its portfolio targets edge AI, robotics, defense, and energy markets, with companies such as Octavo Systems building System-in-Package computing modules.
0 investors
Growth Curve Bio operates an R&D-grade precision fermentation facility specializing in microbial fermentation for synthetic biology programs, serving biotech and life sciences companies developing novel products. The company provides integrated services from strain optimization through pilot-scale manufacturing, combining contract research with GMP-informed documentation and process validation to de-risk commercialization.
0 investors
Hansen Engine is an independent research company that develops a variable-displacement supercharger technology for OEM automotive engines aimed at a global market. Based near Minneapolis, it operates an engine test laboratory and works on advancing automotive engine technologies.
0 investors
Haptech Defense Systems manufactures electronic weapon simulators and drop-in recoil kits for military training, compatible with VR, AR, MR, and live simulation environments. The company's ERIS platform provides simulated recoil and instrumentation without requiring pneumatic infrastructure.
0 investors
HavaH Therapeutics develops T+Ai, a subcutaneous extended-release pellet combining testosterone and anastrozole, aimed at preventing and treating hormone receptor positive breast cancer, including ductal carcinoma in situ (DCIS) and ER+ disease. The clinical-stage company targets the intra-mammary hormonal balance to slow tumor growth and reduce the need for surgery.
0 investors
Heligenics is a genomics and cell biology company that develops assays and platforms for drug screening and genetic analysis. The company serves pharmaceutical and biotech organizations conducting research in functional genomics and cellular engineering.
0 investors
Hepanova is a clinical-stage biotech developing first-in-class oral small-molecule therapeutics for chronic liver diseases and inflammatory conditions, including MASH, liver fibrosis, and IBD. Its lead candidate, HPN-01, is an oral dual IKKΞ±/IKKΞ² inhibitor that has completed a U.S. Phase 1 trial.
0 investors
HexaTech develops and commercializes aluminum nitride (AlN) semiconductor material, using a proprietary crystal growth process to produce single-crystalline AlN boules and substrates with far fewer defects than competing technologies. Its substrates support the fabrication of high-Al-content AlGaN and other III-nitride semiconductor devices.
0 investors
HFR Networks provides optical, packet, and radio access network transport solutions, including Smart Tunable Optics, flexiHaul transport, and FTTX/Carrier Ethernet equipment, for service providers, enterprises, and utility companies. It serves Tier 1 mobile operators, regional fiber builders, and enterprises across Korea, Japan, and North America, supporting 4G/5G and Private 5G deployments.
0 investors
Hidenn.ai offers an engineering simulation platform that combines LLM-guided conversational workflows, automated finite element analysis (FEA) pre-processing and solving, and data-driven and physics-based surrogate modeling. It is aimed at engineers performing computational mechanics and CAE simulations of physical systems.
0 investors